PhotosBiographyFacebookTwitter

From Wikipedia, the free encyclopedia

Miriam van der Have
Born1 November 1958
NationalityDutch
Known for Intersex human rights activist, co-chair of OII Europe and managing director NNID
Website nnid.nl and oiieurope.org

Miriam van der Have is an intersex human rights activist and woman with androgen insensitivity syndrome. She is a co-founder and co-chair of OII Europe e.V in 2015, co-founder and managing director of NNID Foundation in the Netherlands [1] [2] and member of the ILGA board ( International Lesbian, Gay, Bisexual, Trans and Intersex Association) where she is Intersex Secretariat until spring 2019. Van der Have is also a documentary film maker and journalist. [2]

Early life and career

Diagnosed with androgen insensitivity syndrome, [3] and subjected to surgical intervention, [4] van der Have is an intersex human rights advocate and documentary film maker. She has previously worked as a publisher and journalist. Her documentary work includes a film on four intersex women entitled "Vrouwen met AOS" ("Women with AIS"). [2] The documentary premiered on June 15, 2016. [5] [6]

Activism

A former chair of Dutch androgen insensitivity syndrome group AISNederland, [7] van der Have is a founder of NNID Foundation and a co-founder of OII Europe. She "came out" as intersex on a television show in 2003. [4] She speaks and writes widely on intersex issues, promoting the emancipation of intersex people. [6] [4] [8] On Intersex Awareness Day, October 26, 2016, van der Have and Juul van Hoof presented guidance on intersex issues to Minister Jet Bussemaker. [9]

van der Have has stated that, "Intersex variations are not an abnormality or disease. For me intersex refers to the lived experience of the socio-cultural consequences of being born with a body that does not fit within the normative definitions of "man" and "woman." In short, it is about our experiences and not a medical diagnosis." [10] She has called for inclusion of the term " sex characteristics" in Dutch equal treatment legislation. [10]

In December 2016, van der Have was for ILGA elected as the Intersex Secretariat of the International Lesbian, Gay, Bisexual, Trans and Intersex Association, representing NNID. [11]

Selected bibliography

  • "Voeg een I toe aan LHBT: intersekse uit de onzichtbaarheid". Het Parool. August 1, 2014. Retrieved January 12, 2017.
  • Have, M. J. van der; Intven, I. C. a. H.; Barends, A. (June 2008). "Patiënten, ouders, behandelaars en de patiëntenorganisatie". Tijdschrift voor Kindergeneeskunde. 76 (3): 145–147. doi: 10.1007/BF03078194. ISSN  0376-7442. S2CID  76377341.

See also

References

  1. ^ "First ever European Intersex NGO founded. OII Europe sets up work on Intersex Human Right Issues". OII Europe. December 14, 2012.
  2. ^ a b c "OutSummit Speakers 2016". OutRight Action International. 2016. Retrieved January 12, 2017.
  3. ^ Punt, Anne (August 28, 2014). "Duizenden Nederlanders passen niet in het biologische hokje man of vrouw". Vice. Retrieved January 12, 2017.
  4. ^ a b c Cianciotto, Jason (December 24, 2015). "Intersex activism to the fore during UN advocacy push". Gay City News.
  5. ^ "Filmepremière vrouwen met androgeen ongevoeligheid syndroom (AOS)". Atria. 2016. Retrieved January 12, 2017.
  6. ^ a b "Mama Cash Screening documentaire: 'Vrouwen met AOS'". SPE Amsterdam. 2016. Retrieved January 12, 2017.
  7. ^ "Vrijdag 29 maart: Interseksualiteit – Lezing door Miriam van der Have". Transgender Groep Nijmegen. Retrieved January 12, 2017.
  8. ^ "Upcoming event – Professionally Speaking: challenges to achieving equality for LGBTI people". European Parliament Intergroup on LGBT Rights. March 9, 2016. Retrieved January 12, 2017.
  9. ^ "Bussemaker neemt Handreiking Intersekse in ontvangst". COC Nederland. October 26, 2016. Retrieved January 12, 2017.
  10. ^ a b van Heesch, Margriet (July 2016), "85.000 Nederlanders hebben een intersekseconditie. Tijd om hen te leren kennen", De Correspondent
  11. ^ "Board". International Lesbian, Gay, Bisexual, Trans and Intersex Association. Retrieved January 12, 2017.